About ECM Therapeutics
ECM Therapeutics is a company based in Warrendale (United States) founded in 2018.. ECM Therapeutics has raised $26.1 million across 1 funding round. ECM Therapeutics offers products and services including ECM Therapeutic Products and Extracellular Vesicles. ECM Therapeutics operates in a competitive market with competitors including SpringWorks Therapeutics, Augmenix, AmacaThera, Regentis Biomaterials and LifeSprout, among others.
- Headquarter Warrendale, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ecm Therapeutics Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$26.1 M (USD)
in 1 rounds
-
Latest Funding Round
$26.1 M (USD), Series B
May 28, 2018
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ECM Therapeutics
ECM Therapeutics offers a comprehensive portfolio of products and services, including ECM Therapeutic Products and Extracellular Vesicles. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Products from extracellular matrix for tissue repair and inflammation reduction.
Signaling molecules in ECM for regenerative applications in medical treatments.
Unlock access to complete
Funding Insights of ECM Therapeutics
ECM Therapeutics has successfully raised a total of $26.1M through 1 strategic funding round. The most recent funding activity was a Series B round of $26.1 million completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $26.1M
-
First Round
First Round
(28 May 2018)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2018 | Amount | Series B - ECM Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by ECM Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ECM Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ecm Therapeutics Comparisons
Competitors of ECM Therapeutics
ECM Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SpringWorks Therapeutics, Augmenix, AmacaThera, Regentis Biomaterials and LifeSprout, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small molecule therapeutics are developed for cancer and rare diseases.
|
|
| domain | founded_year | HQ Location |
Hydrogel spacers are provided for prostate cancer radiation therapy.
|
|
| domain | founded_year | HQ Location |
Injectable hydrogel platform developed for therapeutic medical applications.
|
|
| domain | founded_year | HQ Location |
Regentis Biomaterials is focused on tissue repair hydrogel technology.
|
|
| domain | founded_year | HQ Location |
Synthetic soft tissue substitutes for cosmetics and reconstructive surgery
|
|
| domain | founded_year | HQ Location |
Developer of nuclear medicines for the treatment of bone cancer treatment & bone marrow ablation
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ecm Therapeutics
Frequently Asked Questions about ECM Therapeutics
When was ECM Therapeutics founded?
ECM Therapeutics was founded in 2018.
Where is ECM Therapeutics located?
ECM Therapeutics is headquartered in Warrendale, United States. It is registered at Warrendale, Pennsylvania, United States.
Is ECM Therapeutics a funded company?
ECM Therapeutics is a funded company, having raised a total of $26.1M across 1 funding round to date. The company's 1st funding round was a Series B of $26.1M, raised on May 28, 2018.
What does ECM Therapeutics do?
ECM Therapeutics was founded in 2018 and is based in Warrendale, United States. Focus is placed on the development of diagnostic and therapeutic products sourced from extracellular matrix, a naturally occurring material. These products address diseases and injuries, including an ECM hydrogel named EsophaGel designed to halt and reverse esophageal cancer progression and precursor stages linked to gastric reflux. Operations center on biotechnology applications for medical treatments.
Who are the top competitors of ECM Therapeutics?
ECM Therapeutics's top competitors include SpringWorks Therapeutics, AmacaThera and Augmenix.
What products or services does ECM Therapeutics offer?
ECM Therapeutics offers ECM Therapeutic Products and Extracellular Vesicles.